Skip to main content

Crinetics Pharmaceuticals, Inc.

CRNXDelisted Sep 1, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001658247

Crinetics Pharmaceuticals, Inc. was delisted on Sep 1, 2026; its insiders filed their last Form 4 on Sep 1, 2026; 267 institutions reported holding it in 13F filings for Q2 2026, worth $4.63B in total; no superinvestor held it.

Q2 2023 vs. Q1 2023

How the institutions holding Crinetics Pharmaceuticals, Inc. changed between Q1 2023 and Q2 2023.

All holders in Q2 2023All holders in Q1 2023

13F holders of CRNX: Q1 2023 compared with Q2 2023
MeasureQ1 2023Q2 2023Change
Holders129140+11
Shares55.1M54.1M−1.00M (−1.8%)
Value$884.3M$974.1M+$89.8M (+10.2%)

New holders (27)

Institutions that held Crinetics Pharmaceuticals, Inc. at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to CRNX in Q2 2023
InstitutionSharesValue% of portfolio
Ikarian Capital, LLC475,000$8.56M3.02%
Jennison Associates LLC461,497$8.32M0.01%
Adage Capital Partners GP, L.L.C.225,000$4.05M0.01%
Boothbay Fund Management, LLC96,805$1.74M0.06%
Prudential Financial Inc71,765$1.29M0.00%
D. E. Shaw & Co., Inc.70,590$1.27M0.00%
AlphaCentric Advisors LLC47,000$846.9K0.47%
Cantor Fitzgerald, L. P.32,562$586.8K0.01%
Squarepoint Ops LLC30,111$542.6K0.00%
Balyasny Asset Management LLC29,089$524.2K0.00%
Tudor Investment Corp Et Al27,028$487.0K0.01%
Jane Street Group, LLC22,120$398.6K0.00%
Campbell & CO Investment Adviser LLC21,594$389.1K0.07%
American Century Companies Inc19,283$347.5K0.00%
Sanders Morris Harris LLC18,600$335.5K0.07%
Hennion & Walsh Asset Management, Inc.18,236$329.0K0.02%
Moore Capital Management, LP17,117$308.4K0.01%
Mackenzie Financial Corp14,909$269.0K0.00%
HSBC Holdings PLC12,327$225.2K0.00%
Dynamic Technology Lab Private Ltd10,442$188.0K0.02%
ProShare Advisors LLC10,431$188.0K0.00%
Aquatic Capital Management LLC3,900$70.0K0.00%
Simplex Trading, LLC2,545$45.0K0.00%
Harbor Capital Advisors, Inc.1,150$20.7K0.00%
West Tower Group, LLC792$14.3K0.01%
CWM, LLC78$1.00K0.00%
Versant Capital Management, Inc31$5590.00%

Sold out (16)

Institutions that held Crinetics Pharmaceuticals, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.